The gut microbiota may determine how effective exercise is on glucose metabolism and insulin sensitivity in patients with prediabetes, a German-Chinese study claims.
When it comes to commercialising microbiome-related products, having really amazing science is only 50% of the journey towards market success, says industry expert Julian Mellentin.
With the deadline for applications to the NutraIngredients Awards fast approaching, our panel of expert judges share some of their top tips and hints of what makes a winning entry.
Psychotropic plant medicine has garnered immense attention as more of such products, most notably cannabidiol (CBD) nutraceuticals, and even foods and beverages, enter the mainstream market.
With the deadline for applications to the NutraIngredients Awards fast approaching, it's vital that you get your applications in soon. But which award should you apply for, and what are the key criteria for the categories? Our helpful video will...
A probiotic strain containing a new type of plasmid could be a ‘promising’ new weapon in the fight against antibiotic bacteria, say the UK Researchers behind the project.
AkzoNobel’s iron compound for use in supplements and fortifying baby foods poses no danger to consumers, say regulators, who rule exposure to nanoparticles possibly in the product as ‘unlikely.’
German pharma firm Bayer is to enter a joint development agreement with Azitra that uses the skin microbiome as a basis for new skin care products that address a range of skin conditions.
Nestlé Health Science and Codexis are to extend a gut health-focused pact that sees the two firms continue to develop a lead candidate to address the gastrointestinal (GI) disorder phenylketonuria.
New products and solutions for personalisation and fortification are key priorities for DSM in APAC for 2020, in order to meet the highly diverse needs of consumers across the region.
A mega-merger between International Flavors & Fragrances Inc (IFF) and DuPont nutrition & biosciences unit will create a new industry giant worth more than $45 billion (€40.4 billion), say those involved in the deal.
Researchers linking the effects of vitamin B3 deficiency to incidences of psychosis could hold the key to solving ‘medical mysteries’ associated with the condition, and may provide hopes for those in developing countries.
An initiative to pool and strengthen nutrition research in Germany is being spearheaded by the country’s federal minister of food and agriculture, Julia Klöckner.
BASF Nutrition & Health are teaming up with Ideogen to introduce an omega-3 fatty acid solution to Europe that addresses the chronic condition Non-Alcoholic Fatty Liver Disease (NAFLD).
Clinical trials involving diet are severely under-funded and more difficult to complete than drugs studies, say researchers who warn that nutrition studies are prone to bias, are often too small and of too short duration and regularly change outcome...
